Bone Health in Menopausal Women – Is MHT Enough?
Menopause-related oestrogen loss accelerates bone decline and fracture risk. While MHT helps preserve bone, it is not always sufficient alone. This course equips healthcare professionals with practical strategies for assessment, prevention, and comprehensive management of bone health in menopausal women.
.jpg)
Learning Outcomes
What you'll learn
- Explain the impact of menopause and oestrogen decline on bone remodelling and fracture risk
- Identify key risk factors for osteoporosis and fragility fractures in menopausal women
- Apply appropriate screening strategies, including BMD testing and fracture risk tools in Australian practice
- Evaluate the role of menopausal hormone therapy (MHT) in preserving bone density and reducing fracture risk
- Differentiate when MHT alone is sufficient and when additional pharmacological treatments are required
- Implement evidence-based lifestyle interventions, including nutrition, exercise and falls prevention
- Develop patient-centred, long-term management plans incorporating monitoring and follow-up
- Collaborate effectively within a multidisciplinary team to optimise bone health outcomes
Stay updated with our


Learning Outcomes
What you'll learn
- Explain the impact of menopause and oestrogen decline on bone remodelling and fracture risk
- Identify key risk factors for osteoporosis and fragility fractures in menopausal women
- Apply appropriate screening strategies, including BMD testing and fracture risk tools in Australian practice
- Evaluate the role of menopausal hormone therapy (MHT) in preserving bone density and reducing fracture risk
- Differentiate when MHT alone is sufficient and when additional pharmacological treatments are required
- Implement evidence-based lifestyle interventions, including nutrition, exercise and falls prevention
- Develop patient-centred, long-term management plans incorporating monitoring and follow-up
- Collaborate effectively within a multidisciplinary team to optimise bone health outcomes
Stay updated with our


Training Overview
- Menopause, Oestrogen Loss and Bone Health
- Risk Factors and Identification in Clinical Practice
- Screening, BMD Assessment and Fracture Risk Stratification
- Menopausal Hormone Therapy (MHT) and Bone Protection
- Beyond MHT – Lifestyle and Pharmacological Management
- Monitoring, Long-Term Care and Multidisciplinary Approach
- Summary
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Top reviews
No reviews yet.
You May Also Like
Are you a qualified
Trainer or Instructor?
Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.
Refer a Friend &
Earn Rewards.
Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.
Frequently asked questions
No. MHT helps reduce bone loss but is not sufficient alone for high-risk women. Additional therapies and lifestyle changes are often needed.
In women over 50 with risk factors or any history of fragility fracture, using DXA scanning.
Weight-bearing and resistance exercises help maintain bone strength and reduce fracture risk.
Yes, through early risk assessment, lifestyle measures, adequate nutrition and appropriate medical treatment.
.jpg)
.jpg)
.jpg)



